ELIZABETH KAMIN: Open Payments
NPI 1124289392 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 56 payments from 8 companies in 2025. Trend: 2023 $1,816 · 2024 $1,718 · 2025 $1,486
Food & beverage: $1,486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $846 |
| E.R. Squibb & Sons, L.L.C. | 11 | $303 |
| Biogen, Inc. | 1 | $115 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Lundbeck LLC | 4 | $70 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: VRAYLAR, COBENFY, REXULTI, ZURZUVAE, Auvelity, TRINTELLIX, CAPLYTA.
Industry payments across VA — which companies pay providers there.
